Alterola Biotech IncOTC Pink - Current Information:ABTI
- LAST PRICE0.0037
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0017/ 1,943
- Ask / Lots0.0490/ 195
- Open / Previous Close0.0000 / 0.0037
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alterola Biotech Inc | 5.1M | -1.4x | --- |
Portage Biotech Inc | 5.0M | 0.0x | --- |
NLS Pharmaceutics AG | 4.9M | -0.2x | --- |
PaxMedica Inc | 5.2M | 0.0x | --- |
Synaptogenix Inc | 4.9M | -0.1x | --- |
Alzamend Neuro Inc | 4.9M | -0.3x | --- |
Company Information
Alterola Biotech, Inc. is a pharmaceutical company. The Company is engaged in the development of cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs); pharmaceutical medicines made from cannabinoid, cannabinoid-like, and non-cannabinoid APIs; and European food approval of cannabinoid-based, cannabinoid-like, and non-cannabinoid ingredients and products. The Company has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. It also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its wholly owned subsidiaries include ABTI Pharma Ltd, Phytotherapeutix Ltd, and Ferven Ltd.
Contact Information
- Headquarters
- 47 Hamilton SquarBIRKENHEAD, CA, United Kingdom CH415AR
- Phone
- 909-584-5853
- Fax
- ---
Executives
- Chairman of the Board, Chief Financial Officer
- Timothy Rogers
- Chief Executive Officer, Director
- David Hitchcock
- Chief Operating Officer, Director
- Colin Stott
- Executive Director
- Daniel Reshef
- Director, Chief Intellectual Property Officer
- Dominic Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.4B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -3.45 |
EPS | $0.00 |
Book Value | $0.01 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
